Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hans H.M. Merks"'
Autor:
Nadège Corradini, Hans H.M. Merks, Keiran McHugh, Max M. van Noesel, Giani Bisogno, Marc H. W. A. Wijnen, Mark N. Gaze, Hélène Martelli, Veronique Minard-Colin, Henry Mandeville, Timothy Rogers, Meriel Jenney, Gian Luca De Salvo, Heidi Glosli, Andrea Ferrari, Anna Kelsey, Daniel Orbach, Ilaria Zanetti, Julia C. Chisholm, Sheila E. J. Terwisscha van Scheltinga, Soledad Gallego
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7580-7589 (2020)
Cancer Medicine
Cancer Medicine
Rhabdomyosarcoma of the extremities present with two main challenges: correct evaluation of initial regional nodal involvement and define adequate local treatment. Methods Pediatric patients with localized rhabdomyosarcoma of the extremity included i
Autor:
Tess Tomassen, Caroline C. Hulsker, Lennart Kester, Laura S. Hiemcke-Jiwa, Hans H.M. Merks, Else Driehuis, Uta Flucke, Joost van Gorp, Max M. van Noesel, Bastiaan B J Tops, Roelof van Ewijk, Sheila E. J. Terwisscha van Scheltinga
Publikováno v:
Annals of Diagnostic Pathology, 52
Loss of histone 3 lysine 27 trimethylation (H3K27me3) has been described as a diagnostic marker for malignant peripheral nerve sheath tumor (MPNST), also discriminating MPNST with rhabdomyoblastic differentiation (malignant Triton tumor) from rhabdom
Autor:
Gianni Bisogno, Hans H.M. Merks
Publikováno v:
Oxford Textbook of Cancer in Children
This chapter discusses soft-tissue sarcomas (STS) in children and adolescents, which comprise approximately 8% of all paediatric malignancies. It highlights the clinical, pathological, and biological characteristics of this heterogeneous group of tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d57923bb1c49d0bdd00486f87c8cb2e
https://doi.org/10.1093/med/9780198797210.003.0025
https://doi.org/10.1093/med/9780198797210.003.0025
Autor:
Max M. van Noesel, Friederike A.G. Meyer-Wentrup, Anke E M van Erp, Laura S van Dam, Uta Flucke, Laurens van Houdt, Mark A.J. Gorris, Thomas Mentzel, Janet Shipley, Yvonne M.H. Versleijen-Jonkers, Marije E. Weidema, Winette T. A. van der Graaf, Melissa H.S. Hillebrandt-Roeffen, C. Dilara Savci-Heijink, Hans H.M. Merks, Ingrid M.E. Desar
Publikováno v:
Oncotarget, 8(41), 71371-71384. Impact Journals
Oncotarget, 8, 71371-71384
Oncotarget, 8, 41, pp. 71371-71384
Oncotarget, 8, 71371-71384
Oncotarget, 8, 41, pp. 71371-71384
Contains fulltext : 181907.pdf (Publisher’s version ) (Open Access) In order to explore the potential of immune checkpoint blockade in sarcoma, we investigated expression and clinical relevance of programmed cell death-1 (PD-1), programmed death li
Autor:
Michela Casanova, Kieran McHugh, Soledad Gallego Melcon, Nathalie Rocourt, Gianni Bisogno, Rick R. van Rijn, Keith Wheatley, Emilie Bogart, Giuseppina Calareso, Hans H.M. Merks, Marie-Cécile Le Deley, Anne-Sophie Defachelles, Susanne A. Gatz, Julia C. Chisholm, Veronique Minard-Colin, Alicia Probst
Publikováno v:
Journal of Clinical Oncology. 37:10000-10000
10000 Background: Vincristine with Irinotecan (VI) is effective in patients with relapsed RMS but outcomes remain poor. The addition of temozolomide to VI (VIT) is attractive owing to different resistance mechanisms and distinct toxicity profiles. Me